Biologix Drives Access & Pricing Innovation at World EPA Congress 2025

On March 5 & 6 in Amsterdam, Biologix reinforced its leadership in shaping healthcare access across MENA at the World Evidence, Access, and Pricing Congress 2025. Engaging with policymakers, healthcare providers, and industry experts, we led discussions on effective access strategies, innovative pricing models, and the evolving role of HEOR/HTA in the region.

Our Market Access & Pricing Lead delivered a key presentation, "The Road to Value: The Progress of HEOR/HTA in the MENA," offering strategic insights to advance evidence-based decision-making.

Beyond participation, Biologix actively champions policies that promote fair pricing and equitable access to life-saving treatments. Through strategic collaborations and thought leadership, we are ensuring that innovative therapies reach those who need them most, and driving real impact in the MENA region.